P842: NOVEL MULTIFUNCTIONAL TETRAVALENT CD38 NKP46 FLEX-NK ENGAGERS ACTIVELY TARGET AND KILL MULTIPLE MYELOMA CELLS

• L. Lin,
• H.-M. Chang,
• C. Nakid,
• S. Frankel,
• D. Wu,
• J. Kadouche,
• D. Teper,
• O. Mandelboim,
• J.-C. Bories,
• A. Arulanandam,
• W. Li

Affiliations

L. Lin

1 Cytovia Therapeutics, Natick, United States of America

H.-M. Chang

1 Cytovia Therapeutics, Natick, United States of America

C. Nakid

2 INSERM U976 and Université de Paris, Paris, France

S. Frankel

1 Cytovia Therapeutics, Natick, United States of America

D. Wu

3 Lynx Biosciences, San Diego

J. Kadouche

4 Cytovia Therapeutics, Aventura, United States of America

D. Teper

4 Cytovia Therapeutics, Aventura, United States of America

O. Mandelboim

5 Hebrew, University of Jerusalem, Jerusalem, Israel

J.-C. Bories

2 INSERM U976 and Université de Paris, Paris, France

A. Arulanandam

1 Cytovia Therapeutics, Natick, United States of America

W. Li

1 Cytovia Therapeutics, Natick, United States of America